Anton Dofferhoff to Hepacivirus
This is a "connection" page, showing publications Anton Dofferhoff has written about Hepacivirus.
Connection Strength
0.045
-
Treatment of acute hepatitis C genotypes 1 and 4 with 8 weeks of grazoprevir plus elbasvir (DAHHS2): an open-label, multicentre, single-arm, phase 3b trial. Lancet Gastroenterol Hepatol. 2019 04; 4(4):269-277.
Score: 0.024
-
Ribavirin steady-state plasma level is a predictor of sustained virological response in hepatitis C-infected patients treated with direct-acting antivirals. Aliment Pharmacol Ther. 2017 11; 46(9):864-872.
Score: 0.022